Published in J Immunol on September 15, 1987
Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol (1988) 5.68
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A (1992) 5.07
Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann Rheum Dis (1994) 1.44
Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci U S A (1994) 1.42
Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am J Pathol (1992) 1.32
Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc Natl Acad Sci U S A (1988) 1.27
Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol (1989) 1.23
Cultured human endothelial cells stimulated with cytokines or endotoxin produce an inhibitor of leukocyte adhesion. J Clin Invest (1988) 1.19
Human endothelial cells: effect of TNF-alpha on peripheral blood mononuclear cell adhesion. Immunology (1991) 1.19
Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology (1995) 0.98
Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3. J Clin Invest (1993) 0.97
T cells and neutrophils exhibit differential adhesion to cytokine-stimulated endothelial cells. Immunology (1990) 0.96
Current imaging strategies in rheumatoid arthritis. Am J Nucl Med Mol Imaging (2012) 0.94
Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha. Ann Rheum Dis (2000) 0.93
Characterization of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejection. Am J Pathol (1990) 0.93
Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency. Br J Cancer (1995) 0.87
Effect of leukotriene B4 and prostaglandin E2 on the adhesion of lymphocytes to endothelial cells. Clin Exp Immunol (1990) 0.86
Anti-tumour efficacy of mouse spleen cells separated with Dolichos biflorus lectin (DBA) in experimental pulmonary metastasis of B16 melanoma cells. Br J Cancer (1990) 0.85
Mechanisms of lymphocyte adhesion to endothelial cells: studies using a LFA-1-deficient cell line. Immunology (1989) 0.84
The immunopathology of acute experimental allergic encephalomyelitis. V. A light microscopic and ultrastructural immunohistochemical analysis of fibronectin and fibrinogen. Am J Pathol (1988) 0.83
Immunopathology of diabetes in the RT6-depleted diabetes-resistant BB/Wor rat. Am J Pathol (1990) 0.83
Interleukin 1 derived from human endothelial cells enhances the binding and chemotactic step of T lymphocyte emigration. Clin Exp Immunol (1988) 0.82
Neopterin release from human endothelial cells is triggered by interferon-gamma. Clin Exp Immunol (1992) 0.82
Interferon-alpha and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells. Clin Exp Immunol (1992) 0.81
Vascular endothelium as a target of immune response in renal transplant rejection. Front Immunol (2014) 0.80
Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s. Trans Am Clin Climatol Assoc (1991) 0.78
Relative increase of inflammatory CD4+ T cells in the cerebrospinal fluid of multiple sclerosis patients and control individuals. Clin Exp Immunol (1990) 0.76
Tumour necrosis factor-alpha stimulates invasiveness of T-cell hybridomas and cytotoxic T-cell clones by a pertussis toxin-insensitive mechanism. Immunology (1992) 0.76
Identification of a human endothelial cell activation antigen that is co-expressed by germinal follicle centre B lymphocytes. Immunology (1992) 0.75
Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer. Br J Cancer (2003) 0.75
In vitro synthesis of immunoglobulin by rheumatoid synovial membrane. J Clin Invest (1968) 4.01
Lymphokine stimulation of collagen accumulation. J Clin Invest (1976) 2.94
The effect of gold salt on lysosomal enzymes of the peritoneal macrophage. Arthritis Rheum (1966) 2.83
The pathogenesis of chronic inflammation in experimental antigen-induced arthritis. II. Preferential localization of antigen-antibody complexes to collagenous tissues. J Exp Med (1972) 2.74
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol (1986) 2.67
IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. Arthritis Rheum (1974) 2.45
T lymphocyte adhesion to endothelial cells: mechanisms demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol (1986) 2.28
Production of interleukin 1 by human endothelial cells. J Immunol (1986) 2.27
Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J Exp Med (1968) 2.27
Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J Cell Physiol (1986) 2.26
Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum. Lancet (1966) 2.19
Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum (1976) 2.18
Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum (1975) 2.09
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Immunofluorescent demonstration of an IgG-B1C complex in synovial lining cells of rheumatoid synovial membrane. Clin Exp Immunol (1969) 2.00
Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum (1976) 1.94
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest (1977) 1.89
Lymphokines in the rheumatoid joint. Arthritis Rheum (1975) 1.87
Electron microscopic observations of immunoreactive cells in the rheumatoid synovial membrane. Arthritis Rheum (1976) 1.75
Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol (1985) 1.67
Negative result: treatment of patients with rheumatoid arthritis with gamma globulin: a double-blind controlled study. Arthritis Rheum (1969) 1.63
Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med (1983) 1.57
Lymphocyte chemotactic activity of human interleukin 1. J Immunol (1984) 1.56
Immunoglobulin and specific antibody synthesis in a chronic inflammatory focus: antigen-induced synovitis. J Immunol (1969) 1.52
Studies of isolated synovial living cells of rheumatoid and nonrheumatoid synovial membranes. Arthritis Rheum (1971) 1.49
Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol (1986) 1.46
Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed. J Lab Clin Med (1968) 1.45
Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex. J Exp Med (1978) 1.45
Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus. J Clin Invest (1969) 1.43
Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation. J Immunol (1978) 1.41
Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane. Arthritis Rheum (1973) 1.41
Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest (1981) 1.41
Effects of bacterial lipopolysaccharide on the binding of lymphocytes to endothelial cell monolayers. J Immunol (1986) 1.41
IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum (1983) 1.39
Effect of a gold salt on the immune response. Arthritis Rheum (1967) 1.38
Viruses and the connective tissue diseases. Ann Intern Med (1971) 1.37
Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest (1989) 1.36
Relation of cellular infiltration of rheumatoid synovial membrane to its immune response. Arthritis Rheum (1974) 1.34
The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice. J Immunol (1982) 1.31
Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum (1972) 1.31
Cold-insoluble complexes and complement levels in systemic lupus erythematosus. N Engl J Med (1969) 1.31
Natural antibodies to procaine amide. Clin Exp Immunol (1968) 1.31
Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum (1986) 1.30
Characterization of a B cell defect in the NZB mouse manifested by an increased ratio of surface IgM to IgD. J Immunol (1978) 1.29
Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest (1986) 1.29
Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice. Clin Exp Immunol (1971) 1.28
Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis. Arthritis Rheum (1981) 1.26
Degradation of immunoglobulins by intracellular proteases in the range of neutral pH. J Immunol (1970) 1.26
Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus. J Clin Invest (1977) 1.26
Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest (1972) 1.26
Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty's syndrome. Clin Exp Immunol (1977) 1.25
Nephrosis in the rat induced by rat kidney extracts. Ann N Y Acad Sci (1965) 1.24
Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol (1989) 1.23
Inhibitor of macrophage migration produced by polymorphonuclear leucocytes. J Reticuloendothel Soc (1970) 1.23
Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis. Clin Exp Immunol (1973) 1.23
Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest (1987) 1.22
Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med (1970) 1.20
Response of the rheumatoid synovial membrane to exogenous immunization. J Clin Invest (1971) 1.20
Diet in the treatment of rheumatoid arthritis. Arthritis Rheum (1983) 1.17
Electron-dense deposits following injection of gold sodium thiomalate and thiomalic acid. Arthritis Rheum (1968) 1.16
IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum (1985) 1.15
Abnormal polyclonal B cell activation in NZB/NZW F1 mice. J Immunol (1977) 1.14
Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers. J Immunol (1986) 1.14
The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol (1978) 1.14
Pathways to chronic inflammation in rheumatoid synovitis. Fed Proc (1987) 1.14
Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4. J Clin Invest (1980) 1.13
Immune interferon enhances the production of interleukin 1 by human endothelial cells stimulated with lipopolysaccharide. J Immunol (1986) 1.12
Electron microscopic study of HLA-DR and monocyte/macrophage staining cells in the rheumatoid synovial membrane. Arthritis Rheum (1986) 1.12
A sensitive solid phase microradioimmunoassay for anti-double stranded DNA antibodies. Arthritis Rheum (1981) 1.12
Lymphokines in rheumatoid synovitis. Ann N Y Acad Sci (1975) 1.11
Human dermal microvascular endothelial cells behave like umbilical vein endothelial cells in T-cell adhesion studies. J Invest Dermatol (1987) 1.11
Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease. J Clin Invest (1974) 1.11
Pathophysiology of rheumatoid arthritis. Fed Proc (1973) 1.10
Interaction of polymorphonuclear leukocytes with immune complexes trapped in joint collagenous tissues. Arthritis Rheum (1979) 1.10
Electron microscopic demonstration of immunoglobulin deposition in rheumatoid cartilage. Arthritis Rheum (1976) 1.10
Cytoplasmic tubular structures in kidney biopsies in systemic lupus erythematosus. Arthritis Rheum (1969) 1.10
Rheumatoid hyperviscosity syndrome. Am J Med (1970) 1.09
An appraisal of tests for native DNA antibodies in connective tissue diseases. Clinical usefulness of Crithidia luciliae assay. Ann Intern Med (1978) 1.08
Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes (1985) 1.08
Light and electron microscopic observations on the synovitis of Reiter's disease. Arthritis Rheum (1966) 1.07
Studies on the anti-inflammatory action of 6-mercaptopurine. J Exp Med (1968) 1.06
Low molecular weight IgM in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum (1981) 1.05
Degradation of immunoglobulin G by lysosomal acid proteases. J Immunol (1970) 1.04
Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera. Arthritis Rheum (1982) 1.04
Basement membrane thickening of postcapillary venules and capillaries in rheumatoid synovium. Immunoelectron microscopic and electron microscopic morphometric analysis. Arthritis Rheum (1987) 1.03
Experimental arthritis produced by injection of mediators of delayed hypersensitivity. Arthritis Rheum (1974) 1.03
Complement-fixing antibodies to bedsonia organisms in Reiter's syndrome and ankylosing spondylitis. Ann Rheum Dis (1968) 1.03
Quantitation of rheumatoid factor by laser nephelometry. Rheumatol Int (1982) 1.03
Subepidermal deposition of immunoglobulin in NZB/NZW F hybrid mice. J Immunol (1975) 1.02
Migration of lymphocytes through endothelial cell monolayers: augmentation by interferon-gamma. Cell Immunol (1988) 1.02
Superinduction of T lymphocyte-endothelial cell (EC) binding by treatment of EC with interleukin 1 and protein synthesis inhibitors. J Immunol (1987) 1.01
Direct lysis of lymphocytes by complement in patients with systemic lupus erythematosus. Arthritis Rheum (1972) 1.01